Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChina SXT Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
China SXT Pharmaceuticals, Inc. Earnings Date And Information
China SXT Pharmaceuticals, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 494,457 for the quarter and had revenue of 1.93 M for the year. China SXT Pharmaceuticals, Inc. has generated $-4 earnings per share over the last year ($-3.57 diluted earnings per share) and currently has a price-to-earnings ratio of -1.24. China SXT Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 17th, 2023 based on prior year's report dates.
China SXT Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q4 2024 | N/A | $2.67 | N/A | $494,457 | $494,457 |
| 12/30/2023 | Q3 2024 | N/A | $2.67 | N/A | N/A | $494,457 |
| 09/28/2023 | Q2 2024 | N/A | -$9.67 | N/A | N/A | $939,583 |
| 07/31/2023 | Q1 2024 | N/A | -$9.67 | N/A | N/A | $469,792 |
| 07/31/2023 | Q4 2023 | N/A | -$5.14 | N/A | N/A | $763,391 |
| 07/31/2023 | Q3 2023 | N/A | -$5.14 | N/A | N/A | $381,696 |
| 09/29/2022 | Q2 2023 | N/A | -$7.30 | N/A | N/A | $1.21 M |
| 07/18/2022 | Q1 2023 | N/A | -$7.30 | N/A | N/A | $604,144 |
| 07/18/2022 | Q4 2022 | N/A | -$25.39 | N/A | N/A | $-11,502,270 |
| 07/18/2022 | Q3 2022 | N/A | -$25.39 | N/A | N/A | $787,304 |
| 01/14/2022 | Q2 2022 | N/A | -$49.71 | N/A | N/A | $1.03 M |
| 08/13/2021 | Q1 2022 | N/A | -$49.71 | N/A | N/A | $513,837 |
| 08/13/2021 | Q4 2021 | N/A | -$71.73 | N/A | N/A | $-9,326,978 |
| 08/13/2021 | Q3 2021 | N/A | -$71.73 | N/A | N/A | $458,536 |
| 09/29/2020 | Q2 2021 | N/A | $24.00 | N/A | N/A | $1.93 M |
| 07/31/2020 | Q1 2021 | N/A | $24.00 | N/A | N/A | $1.93 M |
| 07/31/2020 | Q4 2020 | N/A | -$297.04 | N/A | N/A | $5.16 M |
| 07/31/2020 | Q3 2020 | N/A | -$297.04 | N/A | N/A | $973,560 |
| 04/22/2020 | Q2 2020 | N/A | -$103.32 | N/A | N/A | $3.22 M |
| 08/15/2019 | Q1 2020 | N/A | -$103.32 | N/A | N/A | $1.61 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
China SXT Pharmaceuticals, Inc. Earnings: FAQ's
China SXT Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 17th, 2023 based offlast year's report dates.
The conference call for China SXT Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for China SXT Pharmaceuticals, Inc.'s latest earnings report can be read online.
China SXT Pharmaceuticals, Inc. (:SXTC) has a recorded annual revenue of $1.93 M.
China SXT Pharmaceuticals, Inc. (:SXTC) has a recorded net income of $-3,098,532.China SXT Pharmaceuticals, Inc. has generated $-3.57 earnings per share over the last four quarters.
China SXT Pharmaceuticals, Inc. (:SXTC) has a price-to-earnings ratio of -1.24 and price/earnings-to-growth ratio is -0.03.